Expression of the hippocampal NMDA receptor GluN1 subunit and its splicing isoforms in schizophrenia: postmortem study

. 2010 Jul ; 35 (7) : 994-1002. [epub] 20100305

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid20204507

There is accumulating evidence that disturbances in N-methyl-D: -aspartate receptor (NMDA-R) functioning are associated with the pathogenesis of schizophrenia. To assess actual changes in the expression of the GluN1 subunit and its isoforms, we measured absolute differences in the levels of mRNA/protein for panGluN1 (eight isoforms altogether) as well as the mRNA individual isoforms in the postmortem left/right hippocampus of patients with schizophrenia in comparison with non-psychiatric subjects. There were no significant differences in the panGluN1 subunit mRNA expression, but the absolute left/right differences were much more pronounced in the patients with schizophrenia. Protein levels of the GluN1 subunit in the left hippocampus in male schizophrenic patients were lower than controls. The expression of the NR1-4b isoform was attenuated in the left, whereas the NR1-2b was reduced in the right hippocampus of schizophrenic patients. Isoforms associated with the efficiency of NMDA-induced gene expression and with phosphorylation occurred more commonly in schizophrenic hippocampi. In summary, our study suggests that NMDA-R hypofunction in schizophrenia might be selectively dependent on the dysregulation of GluN1 subunit expression, which exhibits a somewhat different expression in the left/right hippocampus of psychotic patients.

Zobrazit více v PubMed

Mol Psychiatry. 2005 Jan;10(1):40-68; image 5 PubMed

Neurochem Res. 2003 Jun;28(6):919-24 PubMed

J Neurosci. 2006 Jan 25;26(4):1065-76 PubMed

Curr Opin Neurobiol. 2001 Jun;11(3):327-35 PubMed

Acta Psychiatr Scand. 2004 Apr;109(4):269-74 PubMed

Ann N Y Acad Sci. 2003 Nov;1003:94-101 PubMed

Mol Psychiatry. 2006 Feb;11(2):118-9 PubMed

Neurochem Res. 2003 Feb;28(2):235-41 PubMed

Neurochem Int. 2005 Jul;47(1-2):84-91 PubMed

Recent Prog Horm Res. 2002;57:357-84 PubMed

Eur Psychiatry. 2008 Jun;23(4):245-54 PubMed

Curr Opin Pharmacol. 2007 Feb;7(1):48-55 PubMed

Schizophr Res. 2005 Dec 15;80(2-3):323-30 PubMed

Am J Psychiatry. 2001 Sep;158(9):1400-10 PubMed

Nature. 1993 Jul 1;364(6432):70-3 PubMed

Gene. 1993 Sep 15;131(2):293-8 PubMed

J Comp Neurol. 1998 Jan 5;390(1):75-90 PubMed

J Neurochem. 2002 Jun;81(6):1298-307 PubMed

Neuropsychopharmacology. 2007 Sep;32(9):1888-902 PubMed

Neuroreport. 1996 Aug 12;7(12):2051-5 PubMed

Neuroreport. 2001 Sep 17;12(13):2971-4 PubMed

Mol Psychiatry. 2006 Aug;11(8):737-47, 705 PubMed

J Biol Chem. 1997 Feb 21;272(8):5157-66 PubMed

J Neurosci. 1997 Mar 1;17(5):1848-59 PubMed

Acta Psychiatr Scand Suppl. 2000;401:3-38 PubMed

J Neurosci. 2001 May 1;21(9):3063-72 PubMed

Brain Res Mol Brain Res. 1997 Oct 15;50(1-2):136-42 PubMed

Nat Rev Neurosci. 2003 Jan;4(1):37-48 PubMed

J Neurosci. 1996 Jan;16(1):19-30 PubMed

Neurochem Res. 1997 Mar;22(3):249-52 PubMed

Methods Mol Biol. 2000;132:365-86 PubMed

J Neurochem. 2003 May;85(3):543-62 PubMed

Prog Neuropsychopharmacol Biol Psychiatry. 2003 May;27(3):411-7 PubMed

Neuron. 1991 Aug;7(2):319-26 PubMed

Neurochem Int. 2008 Nov;53(5):118-25 PubMed

Nature. 1992 Jul 2;358(6381):36-41 PubMed

Neuroreport. 2000 Apr 7;11(5):983-6 PubMed

Gene. 1995 Jul 4;159(2):219-23 PubMed

Neuron. 2000 Dec;28(3):887-98 PubMed

Am J Psychiatry. 2000 Jul;157(7):1141-9 PubMed

Trends Neurosci. 1995 Jul;18(7):306-13 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...